Prefilled syringes are not only convenient for at-home use, they also offer safety and convenience features for hospital ...

The prefilled syringe presentation offers a convenient administration option to healthcare professionals.

The FDA has approved a new prefilled syringe presentation of Shingrix (zoster vaccine recombinant, adjuvanted).

Prefilled syringe eliminates the need to reconstitute separate vials prior to administration and simplifies the vaccine process.

The U.S. Food and Drug Administration has approved GSK's prefilled syringe presentation of Shingrix (zoster vaccine recombinant, adjuvanted) for the prevention of shingles (herpes zoster).

The US Food and Drug Administration (FDA) has approved GSK's Shingrix vaccine (recombinant zoster vaccine or RZV) in a prefilled syringe presentation to prevent shingles (herpes zoster). This ...

Spikes ≥10 mm Hg occurred most often after syringe injection of methotrexate (>35%); syringe aflibercept (33%); foscarnet ...

The existing vaccine consists of two vials -- a lyophilized (powder) antigen and a liquid adjuvant -- that health care professionals combine prior to administration. The new prefilled syringe ...

Prefilled syringe presentation offers a convenient administration option to healthcare professionals An estimated one million people develop shingles in the US each ...

The FDA has approved a prefilled syringe option of Shingrix which will streamline administration of GSK’s herpes zoster vaccine for adult patients.

BD, a leading global medical technology company, is investing more than $35 million to expand prefilled flush syringe manufacturing at its Columbus, Neb., facility. With the investment, the company ...

The prefilled syringe presentation is licensed in the United States for immunization of adults 50 years and older, as well as those aged 18 years and older who are or will be at increased risk for ...